Basilea Pharmaceutica
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hegenheimermattweg 167b, Allschwil, Base...Phone Number
+41 616061111Website
www.basilea.comRevenue
$187.5 MillionStock Symbol
BSLNIndustry
About Basilea Pharmaceutica
Basilea Pharmaceutica Org Chart
Is Basilea Pharmaceutica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Basilea Pharmaceutica has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Basilea Pharmaceutica launches new products
Check out if Basilea Pharmaceutica is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Basilea Pharmaceutica
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Basilea Pharmaceutica recently announced quarterly report
Basilea Pharmaceutica, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Basilea Pharmaceutica had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Basilea Pharmaceutica has new funding data
Recommended Actions
Find VP level buyers at Basilea Pharmaceutica
Find 2 more new buyers
Company Profile Activity
Activity Insights
Basilea Pharmaceutica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Basilea Pharmaceutica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Basilea Pharmaceutica.
Basilea Pharmaceutica Tech Stack
A closer look at the technologies used by Basilea Pharmaceutica
Most Recent Scoops
Basilea Pharmaceutica News & Media
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
Allschwil, Switzerland, April 15, 2026Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
Ad hoc announcement pursuant to Art. 53 LRBasilea announces start of first‑in‑human study of novel antibiotic BAL2420
Allschwil, Switzerland, March 23, 2026Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Ad hoc announcement pursuant to Art. 53 LR
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Basilea Pharmaceutica
Founded in 2000, Basilea Pharmaceutica is a commercial-stage biopharmaceutical company that specializes in the development of products for the therapeutic areas of oncology and infectious diseases. Basilea Pharmaceutica is located in Switzerland.... Read More